CI
AXDX

Cowen Inc’s Accelerate Diagnostics AXDX Stock Holding History

Cowen Inc’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$197K Buy
+860
New +$168K 0.01% 249
2019
Q1 		– Sell
-2,296
Closed -$264K – 385
2018
Q4 		$264K Buy
+2,296
New +$340K 0.03% 206

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Cowen Inc's AXDX Position: Q2 2019 in Review

Cowen Inc opened a new position in Accelerate Diagnostics (AXDX) in Q2 2019: 860 shares worth $197K. The stake represents 0.01% of the portfolio and ranks #249 among its holdings. This is a return to the name: Cowen Inc previously reported a position in AXDX as recently as Q4 2018.

Cowen Inc first reported a position in AXDX in Q4 2018 and has held it in 2 quarters since. The position peaked at $264K in Q4 2018. 117 funds tracked by Wall St. Rank hold AXDX as of Q2 2019.

  • Cowen Inc held 860 shares of Accelerate Diagnostics worth $197K as of Q2 2019.
  • Accelerate Diagnostics was a new Cowen Inc position in Q2 2019.
  • Accelerate Diagnostics made up 0.01% of Cowen Inc's portfolio in Q2 2019, its #249 holding.
  • Cowen Inc first reported a position in Accelerate Diagnostics in Q4 2018 and has held it in 2 quarters since.
  • Cowen Inc's Accelerate Diagnostics position peaked at $264K in Q4 2018.
  • 117 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.